BIOMARIN PHARMACEUTICAL INC

BMRN

BIOMARIN PHARMACEUTICAL INC

BMRN

Insider Sentiment (TTM):

Last Purchase:-Last Sale:2026-05-07Shares Purchased (TTM):0Shares Sold (TTM):52,154

Institutional Sentiment:

As of:2026-03-31Institutional Shares Owned:178,654,781Shares Outstanding:192,497,000Institutional Ownership Pct.:92.81%

Earnings Market Reaction:

Filing Date:2026-05-05Price on Filing Date:N/APrevious Close:N/A% Change:N/A

Companies in Pharmaceutical Preparations

LLY JNJ ABBV MRK ABT PFE

BIOMARIN PHARMACEUTICAL INC (BMRN) — SEC Financial Statements & Analysis

BIOMARIN PHARMACEUTICAL INC (BMRN) files its annual 10-K and quarterly 10-Q reports directly with the SEC. The financial data below is sourced as-filed from EDGAR — balance sheet, income statement, and cash flow as reported, without normalization or third-party adjustments.

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Financial Statements

10‑Q10‑K

Values in Millions ($)	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30
Assets
Assets Current
Cash And Cash Equivalents At Carrying Value	2,222	1,312	1,250	1,214	1,049	943	675	972	747	755	785	694
Available For Sale Securities Debt Securities Curr…	0	249	228	218	224	195	255	252	300	319	340	477
Accounts Receivable Net Current	904	908	790	856	739	661	778	691	637	634	572	610
Inventory Net	1,273	1,299	1,382	1,340	1,275	1,233	1,179	1,184	1,138	1,107	1,032	976
Other Assets Current	206	186	204	177	182	202	169	160	163	141	225	193
Assets Current	4,605	3,953	3,855	3,805	3,468	3,232	3,057	3,260	2,985	2,956	2,955	2,950
Assets Noncurrent
Available For Sale Securities Debt Securities Nonc…	0	492	513	509	507	521	562	557	621	611	548	386
Property Plant And Equipment Net	958	953	1,038	1,030	1,033	1,043	1,045	1,053	1,060	1,066	1,067	1,067
Intangible Assets Net Excluding Goodwill	205	214	233	240	247	255	261	266	280	295	302	310
Goodwill	196	196	196	196	196	196	196	196	196	196	196	196
Deferred Income Tax Assets Net	1,501	1,509	1,509	1,427	1,461	1,489	1,531	1,545	1,546	1,546	1,524	1,509
Restricted Cash Equivalents Noncurrent	850	-	-	-	-	-	-	-	-	-	-	-
Other Assets Noncurrent	276	277	271	249	236	251	199	191	185	172	165	144
Assets	8,591	7,594	7,615	7,456	7,147	6,989	6,851	7,067	6,873	6,842	6,758	6,563
Liabilities And Stockhold…
Liabilities Current
Accounts Payable And Accrued Liabilities Current	793	759	798	684	628	607	716	573	594	683	670	597
Liabilities Current	793	759	798	684	628	607	716	1,067	1,088	1,177	1,163	597
Business Combination Contingent Consideration Liab…	-	-	-	-	-	-	-	-	-	0	0	0
Convertible Debt Current	-	-	-	-	-	0	0	495	494	494	493	-
Liabilities Noncurrent
Convertible Debt Noncurrent	-	597	597	596	596	595	595	594	594	593	593	1,085
Long Term Debt	1,430	-	-	-	-	-	-	-	-	-	-	-
Other Liabilities Noncurrent	155	151	163	149	130	129	128	119	117	120	105	98
Liabilities	2,379	1,507	1,558	1,429	1,354	1,331	1,438	1,781	1,799	1,890	1,861	1,780
Stockholders Equity
Common Stock Value	0	0	0	0	0	0	0	0	0	0	0	0
Additional Paid In Capital Common Stock	5,967	5,957	5,901	5,852	5,794	5,802	5,740	5,697	5,619	5,612	5,543	5,494
Common Stock Issued Employee Stock Trust	-10	-11	-11	-12	-11	-11	-12	-12	-12	-10	-10	-10
Accumulated Other Comprehensive Income Loss Net Of…	-4	-13	-34	-45	19	62	5	27	-1	-29	6	-19
Retained Earnings Accumulated Deficit	260	154	201	232	-9	-195	-320	-426	-533	-622	-642	-682
Stockholders Equity	6,212	6,087	6,057	6,027	5,793	5,658	5,413	5,286	5,074	4,952	4,897	4,783
Liabilities And Stockholders Equity	8,591	7,594	7,615	7,456	7,147	6,989	6,851	7,067	6,873	6,842	6,758	6,563
Common Stock Par Or Stated Value Per Share	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001
Common Stock Shares Authorized	500	500	500	500	500	500	500	500	500	500	500	500
Common Stock Shares Issued	193	192	192	192	192	191	191	190	190	189	188	188
Shares Outstanding	193	192	192	192	192	191	191	190	190	189	188	188

Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Start free trial

Custom Table

10‑Q10‑K

0/5

Search a metric to start building a table

Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Start free trial

Interactive Financial Visualizations

10‑Q10‑K

Stock Price:

OnOff

Transformations:

0/1

Search a metric to start building a visual

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Earnings Market Reaction

10‑Q10‑K

Fiscal Year	Q1 1 Month	Q1 2 Month	Q1 3 Month	Q2 1 Month	Q2 2 Month	Q2 3 Month	Q3 1 Month	Q3 2 Month	Q3 3 Month	Q4 1 Month	Q4 2 Month	Q4 3 Month
2026	7.61%	10.82%	-	-	-	-	-	-	-	-	-	-
2025	-7.22%	-11.33%	-7.64%	-5.91%	-13.05%	-12.03%	2.24%	14.32%	2.06%	-11.42%	-10.59%	-15.22%
2024	-4.14%	3.21%	5.08%	13.35%	-12.29%	-13.35%	-2.47%	-0.35%	-6.62%	3.23%	-14.26%	-14.11%
2023	-	-	-	5.94%	-2.13%	-7.10%	10.69%	20.76%	15.79%	-5.52%	-1.63%	-13.92%
Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial

Subscribe to unlock 17+ years of financial data and 50+ calculated metrics

Start 7-day free trial

Subscribe to unlock 17+ years of data and 50+ calculated metrics

Start free trial

Performance and Valuation Metrics

Metrics	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30
Liquidity Ratios
Current Ratio	5.81	5.21	4.83	5.56	5.52	5.33	4.27	3.05	2.74	2.51	2.54	4.94
Quick Ratio	4.20	3.50	3.10	3.60	3.49	3.29	2.62	1.95	1.70	1.57	1.65	3.31
Working Capital	3.81B	3.19B	3.06B	3.12B	2.84B	2.63B	2.34B	2.19B	1.90B	1.78B	1.79B	2.35B
Leverage & Debt
Debt to Equity	0.38	0.25	0.26	0.24	0.23	0.24	0.27	0.34	0.35	0.38	0.38	0.37
Interest Coverage TTM	13.71	37.57	57.53	70.00	51.71	38.23	21.63	15.69	12.33	10.72	9.02	6.41
Debt Ratio	0.28	0.20	0.20	0.19	0.19	0.19	0.21	0.25	0.26	0.28	0.28	0.27
Efficiency & Turnover
Asset Turnover TTM	0.41	0.44	0.43	0.42	0.42	0.41	0.40	0.38	0.37	0.37	0.35	0.35
Days Sales Outstanding TTM	92.48	88.88	92.48	92.16	85.14	82.76	89.50	91.76	91.19	82.61	78.36	87.94
Receivables Turnover TTM	3.95	4.11	3.95	3.96	4.29	4.41	4.08	3.98	4.00	4.42	4.66	4.15
Per Share Metrics
Diluted EPS TTM	1.36	1.77	2.71	3.33	2.67	2.17	1.63	1.28	1.03	0.87	0.77	0.51
Free Cash Flow Per Share TTM	3.98	3.78	4.33	3.62	3.27	2.56	1.68	1.21	0.96	0.33	0.19	0.27
Dividend Per Share TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Margin Metrics
Gross Profit Margin TTM	76.53%	77.73%	81.32%	79.56%	79.44%	79.67%	78.86%	79.85%	78.89%	78.01%	77.43%	77.19%
Operating Profit Margin TTM	9.72%	12.71%	19.89%	25.33%	21.00%	16.97%	12.72%	10.30%	8.57%	7.68%	5.80%	4.52%
Net Profit Margin TTM	8.29%	10.83%	16.82%	21.45%	17.76%	14.96%	11.71%	9.91%	8.31%	6.93%	6.36%	4.47%
Growth Metrics
Net Revenue Growth (1Y)	9.90%	12.87%	12.39%	18.36%	19.36%	17.97%	19.14%	15.83%	13.74%	15.42%	15.05%	16.89%
Net Income Growth (1Y)	-48.70%	-18.26%	61.47%	156.15%	154.99%	154.62%	119.21%	156.61%	186.89%	18.43%	75.21%	84.93%
EPS Growth (1Y)	-49.11%	-19.01%	60.13%	153.75%	152.18%	151.68%	116.67%	153.69%	183.55%	16.81%	72.77%	82.28%
Valuation Metrics
P/E TTM	40.46	32.67	19.98	16.05	25.77	29.26	41.53	61.00	80.29	108.03	113.27	162.93
P/B	1.75	1.87	1.72	1.75	2.33	2.21	2.47	2.96	3.25	3.66	3.40	3.41
P/S TTM	3.35	3.54	3.36	3.44	4.58	4.38	4.86	6.05	6.67	7.49	7.21	7.29
Market Cap	10.87B	11.40B	10.40B	10.55B	13.50B	12.49B	13.39B	15.65B	16.50B	18.11B	16.65B	16.29B
Enterprise Value	9.23B	10.68B	9.75B	9.93B	13.05B	12.14B	13.30B	15.77B	16.84B	18.44B	16.95B	16.68B
Calculated Values
Free Cash Flow TTM	767.06M	724.96M	832.13M	694.91M	624.18M	487.42M	319.89M	230.78M	181.82M	62.57M	35.10M	50.21M
Net Debt	-1.64B	-714.50M	-653.45M	-617.65M	-453.15M	-347.70M	-80.82M	116.80M	340.97M	331.85M	300.57M	390.61M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
Valuation Ratios
P/CF TTM
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Insider Transactions

2026-05-07Sale

Owner: Friberg, Gregory R

Title: EVP, Chief R&D Officer

Shares: 3,281

Price/Share: $53.85

Value: $176,681.85

Shares Owned: 51,818

Relationship: Officer

Ownership: Direct

2026-03-11Sale

Owner: Guyer, Charles Greg

Title: EVP, Chief Technical Officer

Shares: 16,486

Price/Share: $60.46

Value: $996,743.56

Shares Owned: 79,953

Relationship: Officer

Ownership: Direct

2026-02-26Sale

Owner: Davis, George Eric

Title: EVP, Chief Legal Officer

Shares: 26,061

Price/Share: $61.36

Value: $1,599,102.96

Shares Owned: 72,453

Relationship: Officer

Ownership: Direct

2026-02-26Sale

Owner: Friberg, Gregory R

Title: EVP, Chief R&D Officer

Shares: 6,326

Price/Share: $60.38

Value: $381,963.88

Shares Owned: 37,578

Relationship: Officer

Ownership: Direct

2025-05-20Sale

Owner: Burkhart, Erin

Title: GVP, Chief Accounting Officer

Shares: 1,786

Price/Share: $59.31

Value: $105,927.66

Shares Owned: 14,173

Relationship: Officer

Ownership: Direct

Filed Date	Owner	Relationship	Title	Ownership	Purchase/Sale	No. Shares	Price Per Share	Value	Shares Owned	Document Type
2026-05-07	Friberg, Gregory R	Officer	EVP, Chief R&D Officer	Direct	Sale	3,281	53.85	$176,681.85	51,818	4
2026-03-11	Guyer, Charles Greg	Officer	EVP, Chief Technical Officer	Direct	Sale	16,486	60.46	$996,743.56	79,953	4
2026-02-26	Davis, George Eric	Officer	EVP, Chief Legal Officer	Direct	Sale	26,061	61.36	$1,599,102.96	72,453	4
2026-02-26	Friberg, Gregory R	Officer	EVP, Chief R&D Officer	Direct	Sale	6,326	60.38	$381,963.88	37,578	4
2025-05-20	Burkhart, Erin	Officer	GVP, Chief Accounting Officer	Direct	Sale	1,786	59.31	$105,927.66	14,173	4
2025-05-02	Hubbard, Cristin	Officer	EVP, Chief Commercial Officer	Direct	Sale	273	64.92	$17,723.16	32,700	4
2025-03-19	Burkhart, Erin	Officer	GVP, Chief Accounting Officer	Direct	Sale	1,295	71.52	$92,618.40	16,955	4
2025-03-06	Guyer, Charles Greg	Officer	EVP, Chief Technical Officer	Direct	Sale	7,034	71.28	$501,383.52	87,655	4
2025-02-24	Burkhart, Erin	Officer	GVP, Chief Accounting Officer	Direct	Sale	1,344	68.38	$91,902.72	13,105	4
2024-11-12	Guyer, Charles Greg	Officer	EVP, Chief Technical Officer	Direct	Sale	5,278	66.37	$350,300.86	68,909	4
2024-08-13	Burkhart, Erin	Officer	GVP, Chief Accounting Officer	Direct	Sale	714	90.00	$64,260.00	14,449	4
2024-05-30	Mueller, Brian	Officer	EVP, Chief Financial Officer	Direct	Sale	5,000	75.19	$375,950.00	72,159	4
2024-05-28	Davis, George Eric	Officer	EVP, Chief Legal Officer	Direct	Sale	40,850	74.88	$3,058,848.00	56,157	4
2024-05-10	Bienaime, Jean Jacques	Director	-	Direct	Sale	20,000	81.14	$1,622,800.00	474,994	4
2024-05-02	Ajer, Jeffrey Robert	Officer	EVP, Chief Commercial Officer	Direct	Sale	5,000	82.91	$414,550.00	66,767	4
2024-05-02	Davis, George Eric	Officer	EVP, Chief Legal Officer	Direct	Sale	1,850	85.01	$157,268.50	56,157	4
2024-04-12	Bienaime, Jean Jacques	Director	-	Direct	Sale	20,000	91.26	$1,825,200.00	474,994	4
2024-04-10	Burkhart, Erin	Officer	GVP, Chief Accounting Officer	Direct	Sale	2,286	90.00	$205,740.00	16,156	4
2024-03-28	Davis, George Eric	Officer	EVP, Chief Legal Officer	Direct	Sale	24,602	88.34	$2,173,340.68	55,856	4
2024-03-06	Bienaime, Jean Jacques	Director	-	Direct	Sale	1,000	86.71	$86,710.00	560,203	4
2024-03-05	Fuchs, Henry J	Officer	President, Worldwide R&D	Direct	Sale	35,341	85.18	$3,010,346.38	212,117	4
2024-03-05	Ajer, Jeffrey Robert	Officer	EVP, Chief Commercial Officer	Direct	Sale	4,000	87.07	$348,280.00	94,047	4
2024-02-27	Bienaime, Jean Jacques	Director	-	Direct	Sale	1,000	90.35	$90,350.00	562,203	4
2024-02-09	Bienaime, Jean Jacques	Director	-	Direct	Sale	15,000	88.28	$1,324,200.00	419,602	4
2024-01-10	Bienaime, Jean Jacques	Director	-	Direct	Sale	10,000	96.38	$963,800.00	425,162	4
2023-12-21	Bienaime, Jean Jacques	Director	-	Direct	Sale	10,000	93.99	$939,900.00	425,112	4
2023-12-13	Davis, George Eric	Officer	EVP, Chief Legal Officer	Direct	Sale	13,764	95.30	$1,311,709.20	55,710	4
2023-08-16	Ajer, Jeffrey Robert	Officer	EVP, Chief Commercial Officer	Direct	Sale	5,000	90.00	$450,000.00	60,804	4
2023-08-10	Fuchs, Henry J	Officer	President, Worldwide R&D	Direct	Sale	12,000	90.43	$1,085,160.00	176,187	4
2023-08-09	Guyer, Charles Greg	Officer	EVP, Chief Technical Officer	Direct	Sale	5,360	93.30	$500,088.00	40,041	4
2023-08-08	Bienaime, Jean Jacques	Director,Officer	Chief Executive Officer	Direct	Sale	6,000	88.29	$529,740.00	422,732	4
2023-08-08	Davis, George Eric	Officer	EVP, Chief Legal Officer	Direct	Sale	11,000	89.42	$983,620.00	69,474	4
2023-05-11	Bienaime, Jean Jacques	Director,Officer	Chief Executive Officer	Direct	Sale	30,000	94.88	$2,846,400.00	426,213	4
2023-05-10	Bienaime, Jean Jacques	Director,Officer	Chief Executive Officer	Direct	Sale	30,000	95.00	$2,850,000.00	426,213	4
Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Institutional Ownership

No data available for chart

2026-03-31

92.81%

Inst. Shares: 178,654,781

Shares Outstanding: 192,497,000

2025-12-31

95.09%

Inst. Shares: 182,374,478

Shares Outstanding: 191,787,000

2025-09-30

90.63%

Inst. Shares: 174,035,634

Shares Outstanding: 192,032,000

2025-06-30

93.68%

Inst. Shares: 179,778,071

Shares Outstanding: 191,907,000

2025-03-31

92.32%

Inst. Shares: 176,294,111

Shares Outstanding: 190,967,000

Date	Institutional Shares Owned	Shares Outstanding	Institutional Ownership %
2026-03-31	178,654,781	192,497,000	92.81%
2025-12-31	182,374,478	191,787,000	95.09%
2025-09-30	174,035,634	192,032,000	90.63%
2025-06-30	179,778,071	191,907,000	93.68%
2025-03-31	176,294,111	190,967,000	92.32%
2024-12-31	178,459,045	190,027,000	93.91%
2024-09-30	172,172,232	190,429,000	90.41%
2024-06-30	176,949,640	190,114,000	93.08%
2024-03-31	170,597,610	188,866,000	90.33%
2023-12-31	174,414,662	187,834,000	92.86%
2023-09-30	164,814,495	188,219,000	87.57%
2023-06-30	165,134,761	187,948,000	87.86%
Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial

BIOMARIN PHARMACEUTICAL INC (BMRN) — SEC Financial Statements & Analysis

Research Faster.Invest Smarter.

Research Faster.
Invest Smarter.